Updates are available Correction dated 2024-07-23
Click to view Correction: https://doi.org/10.1007/s13671-024-00438-8
-
Authors
Rinderknecht, Fatuma-Ayaan
Nwandu, Lotanna
Daneshjou, Roxana
Lester, Jenna
- License Information
-
More Information
Article History
Accepted: 27 June 2024
First Online: 10 July 2024
Change Date: 23 July 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s13671-024-00438-8
Declarations
:
: Dr Daneshjou reported stock options from Revea and MDalgorithms, as well as personal fees from Pfizer, Frazier Healthcare Partners, and L’Oreal outside the submitted work; in addition, Dr Daneshjou had a patent for 17/937 714 pending and was a member of American Academy of Dermatology (AAD) Augmented Intelligence Committee. Dr Lester reports stock options at Mattice Biosciences; personal fees from L’Oréal both unrelated to the submitted work.
